Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18969042 | 0.91 | SIGMAR1 (0.32) | SIGMAR1 | |
| SCHEMBL18969059 | 0.89 | SIGMAR1 (0.35) | SIGMAR1CYP1A2ALDH1A1THRBHPGD | |
| SCHEMBL18968954 | 0.89 | SIGMAR1 (0.33) | SIGMAR1CYP1A2FYNAHR | |
| SCHEMBL18287512 | 0.88 | MEN1 (0.37) | SIGMAR1 | |
| SCHEMBL18969029 | 0.88 | MCL1 (0.34) | SIGMAR1CYP2C9CYP2C19 | |
| SCHEMBL18969011 | 0.87 | CHRNA1 (0.31) | SIGMAR1 | |
| SCHEMBL18969044 | 0.86 | ALDH1A1 (0.32) | CYP1A2ALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL18969080 | 0.86 | TDP1 (0.33) | ALDH1A1HPGDAHR | |
| SCHEMBL18969026 | 0.86 | SIGMAR1 (0.33) | SIGMAR1CYP1A2ALDH1A1THRBHPGD | |
| SCHEMBL18969024 | 0.84 | CHRNA1 (0.31) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10361374-B2 | Amine compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-23 | — | — | US | disclosed |
| US-20170170402-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170402-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170402-A1 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | AOC2, MAOA, AOC3 | SIGMAR1 419/4885CYP1A2 62/4885ALDH1A1 78/4885 |
| US-10361374-B2 | Amine compound and organic light emitting device including the same | AOC2, MAOA, AOC3 | SIGMAR1 419/4885CYP1A2 62/4885ALDH1A1 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.